[3]Beausoleil C, Beronius A, Bodin L, et al. Review of non-monotonic dose-responses of substances for human risk assessment. 2016.
[4]Bonde J.P., Flachs E.M., Rimborg S. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis. Hum Reprod Update. 2016;23:104-125. 1
[5]Factor-Litvak P., Insel B., Calafat A.M. Persistent associations between maternal prenatal exposure to phthalates on child IQ at age 7 years. PLoS One. 2014;9:e114003. 12
[6]Kalloo G., Calafat A.M., Chen A. Early life triclosan exposure and child adiposity at 8 years of age: a prospective cohort study. Environ Health. 2018;17:24. 1
[7]Comité de la prévention et de la précaution. Les perturbateurs endocriniens, quels risques ? Paris : Ministère de l’Écologie et du Développement Durable, 2004.
[8]Kristensen D.M., Hass U., Lesne L. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod Update. 2011;26:235-244. 1